Cite
HARVARD Citation
Padovani, A. et al. (2022). "Real‐world" eligibility for aducanumab depends on clinical setting and patients' journey. Journal of the American Geriatrics Society. 70 (2), pp. 626-628. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Padovani, A. et al. (2022). "Real‐world" eligibility for aducanumab depends on clinical setting and patients' journey. Journal of the American Geriatrics Society. 70 (2), pp. 626-628. [Online].